A Study of TAK-659 as a Single Agent in Adult East Asian Participants With Non-Hodgkin Lymphoma (NHL)
Clinical trial NCT03238651 · TERMINATED
Trial details
- NCT number
- NCT03238651
- Sponsor
- Calithera Biosciences, Inc
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-08-01
- Primary completion
- 2020-08-17
- Enrollment
- 17
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.